Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
γδ T Cell Immunotherapy in NSCLC
NCT02425748Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jun 2017
- Primary completion
- Dec 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of gamma-delta T cells in non-small cell lung cancer (NSCLC), sponsored by Fuda Cancer Hospital. Started Jun 2017; status: completed.
02
Drugs
gamma-delta T cells
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02425748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425748.